Trials / Conditions / Relapsed Acute Leukemia

Relapsed Acute Leukemia

4 registered clinical trials studyying Relapsed Acute Leukemia — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Withdrawn	A Phase I Study Investigating the Combination of Cladribine, Low Dose Cytarabine and Sorafenib Alternating Wit NCT06474663	M.D. Anderson Cancer Center	Phase 1
Recruiting	A Phase I Study of Hyper-CVAD In Combination With Venetoclax In Pediatric Patients With Relapsed or Refractory NCT06466395	M.D. Anderson Cancer Center	Phase 1
Terminated	A Phase 1 Trial of TST of PD 0332991 Followed by Cytarabine and Mitoxantrone for Adults With Relapsed and Refr NCT01701375	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	Phase 1
Completed	Study of VELCADE® With Mitoxantrone and Etoposide for Leukemias NCT00410423	Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University	Phase 1 / Phase 2